95%,内毒素<1.0EU/μg,-25~-15℃保存1年,多规格可选。" data-qmeta="description">

永利3044(中国集团)有限公司官网

分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Phage-associated Cas12p nucleases require binding to bacterial thioredoxin for activation and cleavage of target DNA

Wang Zhipeng, Wang Yujue, Gao Hui, Dai Jiani, Tang Na, Wang Yannan, Ji Quanjiang

Journal:Nature Microbiology

IF:18.7

DOI:10.1038/s41564-025-02224-z

PMID:41492065

Published:2026-01-02

research field:免疫疗法癌症研究药学纳米技术

Abstract

The evolutionary competition within phage–host systems led to the emergence of CRISPR–Cas defence mechanisms in bacteria and anti-CRISPR elements in bacteriophages. Although anti-CRISPR elements are well characterized, the role of bacterial factors that influence CRISPR–Cas efficacy has been comparatively overlooked. Type V CRISPR–Cas12 systems display striking functional and mechanistic diversity for nucleic acid targeting. Here we use a bioinformatic approach to identify Cas12p, a phage-associated nuclease that forms complexes with the bacterial thioredoxin protein TrxA to enable target DNA degradation. This represents an unexpected phage–bacteria interaction, in which the bacteriophage co-opts a bacterial factor to augment its own genome degradation machinery, potentially against competing phages. Biochemical characterization, cryo-EM-based structural analysis of the Cas12p–TrxA–sgRNA–dsDNA complex at 2.67 Å and bacterial defence assays reveal that TrxA directly binds and activates Cas12p, enabling its nuclease activity and subsequent CRISPR immunity. These findings expand our understanding of the multilayered intricacies of phage–bacteria molecular interactions.

本文使用的Yeasen产品

购物车
客服
转染试用
XML 地图